For the third year in the row, the Great Meadow International CICO3* in The Plains, Virginia, hosted the only leg of the FEI Eventing Nations Cup that takes place on North American soil. Australia, Canada, Great Britain, Switzerland, and the United States were all represented within the 46 horse-and-rider field. After three years of chasing the top of the podium, Great Britain emerged victorious in the Nations Cup, followed by Canada in second place and the United States in third. Individually, Will Coleman and 9-year-old Off The Record rose to the top of the leaderboard after an influential day of cross-country. The USEA was there soaking up the beautiful weather and capturing all the action through the lens.
The USEA Emerging Athletes U21 (EA21) program was established in 2022 with the aim of creating a pipeline for potential U.S. team riders by identifying and developing young talent and pairing them up with influential educators within the sport of eventing to improve their skills both in and out of the saddle.
Macyn Wolpert and her pony 18-year-old Sport Pony Hallelujah were set to attend the Pine Top Intermediate Horse Trials (Thomson, Georgia) on Feb. 11 with cross-county day happily occurring on Wolpert’s 12th birthday.
There aren’t many riders who can say they competed at five of the world’s seven five-star events in 2023, but the 2023 World Equestrian Brands USEA Rider of the Year Boyd Martin can. With nine starts across the Land Rover Kentucky Three-Day Event, Longines Luhmühlen Horse Trials (Germany), Defender Burghley Horse Trials (England), MARS Maryland 5 Star, and Pau (France), Martin earned five top-5 finishes.
The U.S. Equestrian Federation has announced the combinations selected to compete in the 2024 USEF Futures Team Challenge at the Carolina International CCI and Horse Trials, from March 14-17 in Raeford, North Carolina. The Challenge is designed to replicate the experience of competing within a team environment and thus is a training opportunity embedded within an existing competition at the CCI3* and CCI4* levels.